Related Experiment Video
Updated: Jan 7, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
A Proposed Algorithm for the Management of Patients with Cardiogenic Shock Based on Contemporary Knowledge and Gaps
Aidonis Rammos1, Christos D Floros1, Ioannis Tzourtzos1
1Second Department of Cardiology, University Hospital of Ioannina, 45500 Ioannina, Greece.
Cardiogenic shock (CS) management requires improved evidence for intravenous therapies and mechanical circulatory support (MCS). A proposed algorithm highlights gaps, emphasizing early diagnosis and organized care to improve patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) presents a significant challenge with high mortality, even with advanced cardiac intensive care units (CICUs).
- Current therapeutic strategies rely on intravenous (i.v.) pressors and mechanical circulatory support (MCS) devices, guided by CS profile, etiology, and SCAI stage.
- Significant evidence gaps and controversies exist regarding optimal i.v. medications and MCS device utilization, compounded by variable availability and center experience.
Purpose of the Study:
- To propose an evidence-based algorithm for cardiogenic shock (CS) management.
- To identify and delineate critical gaps in the current therapeutic approaches for CS.
- To suggest strategies for bridging therapeutic disparities and improving CS outcomes.
Main Methods:
- This review synthesizes existing literature and clinical guidelines on cardiogenic shock (CS) management.
- An algorithm for CS management is developed, detailing therapeutic steps and decision points.
- Gaps in evidence and clinical practice at each stage of the proposed algorithm are identified.
Main Results:
- The proposed algorithm outlines a structured approach to CS management, incorporating i.v. therapies and mechanical circulatory support (MCS).
- Key evidence gaps were identified concerning the efficacy and selection of specific i.v. medications and MCS devices.
- Disparities in device availability and institutional experience were noted as significant challenges.
Conclusions:
- Addressing the identified evidence gaps through large-scale trials is crucial for optimizing CS treatment.
- Enhanced health system organization, including the establishment of specialized shock centers, is recommended.
- Early clinical suspicion, prompt diagnosis, and standardized management protocols are essential to improve outcomes in cardiogenic shock (CS).
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure V: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care

